With the aim to establish novel molecular mechanisms underlying glioma cell radioresistance, this study proposed a hypothesis that MAGT1 may regulate the ERK/MAPK signaling pathway and PD-L1 in glioma. This evidence concerns the gene MAGT1 and central nervous system cancer.